Investments
52Portfolio Exits
14Funds
4About 6 Dimensions Capital
6 Dimensions Capital, formed from the merger of Frontline BioVentures and WuXi Healthcare Ventures, is a healthcare-focused investment firm.
6 Dimensions Capital Headquarter Location
Suite 1106, Building A, SCG Parkside, 868 Lane, Yinghua Road Pudong New District
Shanghai, Shanghai, 201204,
China
+86 (021) 5046-2227
Latest 6 Dimensions Capital News
Nov 11, 2021
All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.
6 Dimensions Capital Investments
52 Investments
6 Dimensions Capital has made 52 investments. Their latest investment was in Halda Therapeutics as part of their Series A on December 12, 2021.
6 Dimensions Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
12/10/2021 | Series A | Halda Therapeutics | $40.1M | Yes | 1 | |
11/11/2021 | Series A | Ignis Therapeutics | $180M | Yes | 9 | |
11/1/2021 | Series B | Neusoft Zhirui | $39.06M | No | 1 | |
10/5/2021 | Series B | |||||
9/7/2021 | Series C |
Date | 12/10/2021 | 11/11/2021 | 11/1/2021 | 10/5/2021 | 9/7/2021 |
|---|---|---|---|---|---|
Round | Series A | Series A | Series B | Series B | Series C |
Company | Halda Therapeutics | Ignis Therapeutics | Neusoft Zhirui | ||
Amount | $40.1M | $180M | $39.06M | ||
New? | Yes | Yes | No | ||
Co-Investors | |||||
Sources | 1 | 9 | 1 |
6 Dimensions Capital Portfolio Exits
14 Portfolio Exits
6 Dimensions Capital has 14 portfolio exits. Their latest portfolio exit was TScan Therapeutics on July 16, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
7/16/2021 | IPO | 6 | |||
7/13/2021 | IPO | 4 | |||
9/21/2020 | Acquired | 24 | |||
Date | 7/16/2021 | 7/13/2021 | 9/21/2020 | ||
|---|---|---|---|---|---|
Exit | IPO | IPO | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 6 | 4 | 24 |
6 Dimensions Capital Acquisitions
3 Acquisitions
6 Dimensions Capital acquired 3 companies. Their latest acquisition was Gloria Biotech on August 17, 2018.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
8/17/2018 | Corporate Majority | 2 | ||||
5/18/2017 | ||||||
5/18/2017 |
Date | 8/17/2018 | 5/18/2017 | 5/18/2017 |
|---|---|---|---|
Investment Stage | |||
Companies | |||
Valuation | |||
Total Funding | |||
Note | Corporate Majority | ||
Sources | 2 |
6 Dimensions Capital Fund History
4 Fund Histories
6 Dimensions Capital has 4 funds, including 6 Dimensions Capital.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/7/2017 | 6 Dimensions Capital | Diversified Private Equity | Closed | 1 | |
12/7/2017 | 6 Dimensions Capital RMB LP | ||||
6 Dimensions Capital Fund I | |||||
6 Dimensions Affiliates Fund |
Closing Date | 12/7/2017 | 12/7/2017 | ||
|---|---|---|---|---|
Fund | 6 Dimensions Capital | 6 Dimensions Capital RMB LP | 6 Dimensions Capital Fund I | 6 Dimensions Affiliates Fund |
Fund Type | Diversified Private Equity | |||
Status | Closed | |||
Amount | ||||
Sources | 1 |
6 Dimensions Capital Team
5 Team Members
6 Dimensions Capital has 5 team members, including current Chief Executive Officer, Leon Chen.
Name | Work History | Title | Status |
|---|---|---|---|
Leon Chen | Chief Executive Officer | Current | |
Wei Li | Founding Partner | Current | |
Ching Zhu | Frontline BioVentures, Action Medical, and Novitas Capital | Managing Partner | Current |
Qingsheng Zhu | Managing Partner | Current | |
Wei Li | Fidelity Investments, Baird Venture Partners, and Vertex Pharmaceuticals | Managing Partner | Former |
Name | Leon Chen | Wei Li | Ching Zhu | Qingsheng Zhu | Wei Li |
|---|---|---|---|---|---|
Work History | Frontline BioVentures, Action Medical, and Novitas Capital | Fidelity Investments, Baird Venture Partners, and Vertex Pharmaceuticals | |||
Title | Chief Executive Officer | Founding Partner | Managing Partner | Managing Partner | Managing Partner |
Status | Current | Current | Current | Current | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.